Qinglin Zha

1.2k citations
42 papers · 876 indexed · h-index 17
Topics
Traditional Chinese Medicine Studies (18 papers)Rheumatoid Arthritis Research and Therapies (16 papers)Pharmacological Effects of Natural Compounds (13 papers)

In The Last Decade

Qinglin Zha

42 papers receiving 851 citations

Peers

Qinglin Zha
Comparison fields: 5 of 103
  • Molecular Biology 432
  • Complementary and alternative medicine 377
  • Pharmacology 189
  • Rheumatology 135
  • Pharmacology 94
Replace Xuyan Niu with:
Xuyan Niu China
Rongrong Zhou China
Wei Xiao China
Junling Ren China
Yongqing Hua China
Lin Rui-chao China
Robert‐Jan A. N. Lamers Netherlands
Qinglin Zha relative to Xuyan Niu China Xuyan Niu's profile →
Citations per field
00.5×1.5×2.1×
Xuyan Niu · 1×
Citations per year

Countries citing papers authored by Qinglin Zha

Since Specialization
Citations

This map shows the geographic impact of Qinglin Zha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Zha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Zha more than expected).

Fields of papers citing papers by Qinglin Zha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglin Zha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Zha. The network helps show where Qinglin Zha may publish in the future.

Co-authorship network of co-authors of Qinglin Zha

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglin Zha. A scholar is included among the top collaborators of Qinglin Zha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglin Zha. Qinglin Zha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 17
2 102
3 13
4 8
5 22
6 37
7 78
8
Based on Data Warehouse Technique to Uncover the Rule of Treating and Diagnosing Asthma from Incunabula TCM Medical Records
1
9 21
10 9
11 43
12 21
13 20
14 65
15 41
16 1
17 71
18 3
19 4
20 16

About Qinglin Zha

Qinglin Zha is a scholar working on Complementary and alternative medicine, Pharmacology and Rheumatology, having authored 42 papers that have together received 876 indexed citations. Recurring topics across this work include Traditional Chinese Medicine Studies (18 papers), Rheumatoid Arthritis Research and Therapies (16 papers) and Pharmacological Effects of Natural Compounds (13 papers). The work is most often cited by research in Complementary and alternative medicine (377 citations), Pharmacology (189 citations) and Rheumatology (135 citations). Qinglin Zha has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Aiping Lü, Cheng Lü, Miao Jiang, Yiting He, Cheng Xiao, Ying‐Ping Wang, Hua Zhou, Baoming Huang, Shengyuan Xiao and Pei Luo. Their work appears in journals such as The Lancet, Journal of Ethnopharmacology and RSC Advances.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026